DNA vaccination favours memory rather than effector B cell responses.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 1905479)

Published in Clin Exp Immunol on July 01, 1999

Authors

R Laylor1, N Porakishvili, J B De Souza, J H Playfair, P J Delves, T Lund

Author Affiliations

1: Medical Molecular Biology Unit, Department of Immunology, The Windeyer Institute for Medical Sciences, UCL, London, UK.

Articles cited by this

Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature (1981) 13.89

CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24

Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39

Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14

Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 5.30

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A (1996) 5.26

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med (1997) 4.06

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82

DNA-based immunization by in vivo transfection of dendritic cells. Nat Med (1996) 3.62

Synthesis of calf prochymosin (prorennin) in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.13

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med (1997) 1.81

Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques (1991) 1.46

Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol (1997) 1.45

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature (1998) 1.41

The construction of a highly efficient and versatile set of mammalian expression vectors. Nucleic Acids Res (1989) 1.30

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity. Proc Natl Acad Sci U S A (1997) 1.27

Immunization with DNA. J Immunol Methods (1994) 1.22

A vaccine that prevents pregnancy in women. Proc Natl Acad Sci U S A (1994) 1.16

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med (1997) 1.07

Liposome-mediated DNA vaccination. FEBS Lett (1997) 0.99

Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine (1997) 0.86

Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120. Clin Exp Immunol (1997) 0.85

Identification and selective destruction of shared epitopes in human chorionic gonadotropin beta subunit. J Reprod Immunol (1996) 0.85

Genetic immunization with the free human chorionic gonadotropin beta subunit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice. Lab Invest (1997) 0.84

The immune response to HIV gp120 induced by nucleic acid immunization (NAI). Ann N Y Acad Sci (1995) 0.81

Epitopes of human chorionic gonadotropin and their relationship to immunogenicity and cross-reactivity of beta-chain mutants. Am J Reprod Immunol (1998) 0.77

Articles by these authors

The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05

The construction of cosmid libraries which can be used to transform eukaryotic cells. Nucleic Acids Res (1982) 5.66

Retracted Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood (2001) 3.46

Accuracy of pedicle screw insertion with and without computer assistance: a randomised controlled clinical study in 100 consecutive patients. Eur Spine J (2000) 3.38

Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12

Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09

Bacillus cereus and its food poisoning toxins. FEMS Microbiol Lett (1997) 3.00

Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98

Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56

Structure of the murine immune response I-A beta locus: sequence of the I-A beta gene and an adjacent beta-chain second domain exon. Cell (1983) 2.42

Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42

Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34

Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30

Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09

Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03

Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02

Exposure to deer blood may be a cause of human granulocytic ehrlichiosis. Clin Infect Dis (1996) 1.94

Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91

Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82

Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79

Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79

Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78

Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78

Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77

Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76

Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75

The complete nucleotide sequence of the I-E alpha d immune response gene. Nucleic Acids Res (1983) 1.75

Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74

The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67

The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65

Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64

Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62

Biomechanics of stand-alone cages and cages in combination with posterior fixation: a literature review. Eur Spine J (2000) 1.61

The sequence of the non-haemolytic enterotoxin operon from Bacillus cereus. FEMS Microbiol Lett (1999) 1.61

Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59

On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett (1983) 1.59

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions. Leuk Res (2008) 1.58

Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57

Long-term prognosis of cirrhosis after spontaneous bacterial peritonitis treated with ceftriaxone. J Clin Gastroenterol (2001) 1.56

Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52

Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48

Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45

Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45

Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42

Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol (1991) 1.41

Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS (1997) 1.40

Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40

Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39

Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38

Isolation of transforming DNA by cosmid rescue. Proc Natl Acad Sci U S A (1982) 1.38

Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36

Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35

Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34

Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34

Immunity to malaria. Br Med Bull (1982) 1.34

Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31

Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30

Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27

The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24

A new approach to computer-aided spine surgery: fluoroscopy-based surgical navigation. Eur Spine J (2000) 1.23

Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23

Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21

Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20

Computer-assisted spine surgery. Eur Spine J (2000) 1.20

Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19

Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17

Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15

What comprises a good outcome in spinal surgery? A preliminary survey among spine surgeons of the SSE and European spine patients. Eur Spine J (2007) 1.15

The relative importance of vertebral bone density and disc degeneration in spinal flexibility and interbody implant performance. An in vitro study. Spine (Phila Pa 1976) (1996) 1.14

Two distinct types of non-specific immunosuppression in murine malaria. Clin Exp Immunol (1980) 1.14

Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14

Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14

Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy (2007) 1.14

A minority of patients with rheumatoid arthritis show a dominant rearrangement of T-cell receptor beta chain genes in synovial lymphocytes. Scand J Immunol (1987) 1.13

B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13

The human chromosomal protein HMG I contains two identical palindrome amino acid sequences. Biochem Biophys Res Commun (1987) 1.13

Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13

Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13

On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cells. FEBS Lett (1985) 1.12

Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12

Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12

Does hCG or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol (2010) 1.11

Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11

Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10

Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10

Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09

Compressive strength of interbody cages in the lumbar spine: the effect of cage shape, posterior instrumentation and bone density. Eur Spine J (1998) 1.09

Macrophages as effector cells in immunity to malaria. Immunol Lett (1985) 1.09

Chemotactic factor-induced membrane potential changes in rabbit neutrophils monitored by the fluorescent dye 3,3'-dipropylthiadicarbocyanine iodide. Biochim Biophys Acta (1980) 1.07

Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect Immun (2000) 1.07

CytK toxin of Bacillus cereus forms pores in planar lipid bilayers and is cytotoxic to intestinal epithelia. FEMS Microbiol Lett (2001) 1.06